The pharmacokinetic profile of sitaxsentan, a selective endothelin receptor antagonist, in varying degrees of renal impairment

AIM: To investigate the pharmacokinetic profile of a single 100-mg oral dose of sitaxsentan, a selective endothelin type A receptor antagonist, in subjects with normal and impaired renal function. METHODS: This was an open label, single oral dose study in subjects with normal [creatinine clearance (...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Dhaun, Neeraj, Melville, Vanessa, Kramer, William, Stavros, Fiona, Coyne, Terrance, Swan, Suzanne, Goddard, Jane, Webb, David J
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Science Inc 2007
Teme:
Pharmacokinetics in Renal Insufficiency and Dialysis
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2198787/
https://ncbi.nlm.nih.gov/pubmed/17635499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2007.02979.x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items